In a bid to bolster its footing in providing surgical treatments, Johnson & Johnson has announced it will acquire robotics specialist Auris Health via its subsidiary Ethicon in a deal worth potentially $5.75 million in cash.
This total value breaks down into an upfront cash payment of $3.4 billion and $2.35 billion in milestone payments.
![[column] Toekomst tijdschriften glanst als nooit tevoren](https://www.pharmamarketeer.nl/wp-content/uploads/2024/12/happy-couple-in-t-shirts-reading-newspaper-while-h-2024-11-10-00-13-23-utc-1-80x60.jpg)
![[column] MarketingAffairs 17: Marketing als oplossing](https://www.pharmamarketeer.nl/wp-content/uploads/2024/12/asian-seo-manager-writing-on-glass-with-illustrati-2024-11-17-23-11-51-utc-1-80x60.jpg)
